SAMANTHA WOJCIK: Open Payments
NPI 1225481013 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,468 in 73 payments from 18 companies in 2025. Trend: 2023 $1,298 · 2024 $1,703 · 2025 $1,468
Food & beverage: $1,468
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $252 |
| ABBVIE INC. | 11 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $151 |
| Lilly USA, LLC | 7 | $135 |
| Novo Nordisk Inc | 6 | $125 |
| Grifols USA, LLC | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
Products named: XIFAXAN, BREZTRI, MOUNJARO, REXULTI, FARXIGA, Prolastin-C Liquid, FANAPT, QULIPTA.
Industry payments across IN — which companies pay providers there.
